Progressive scoliosis in central core disease by Mertz, Kirsten D et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2005
Progressive scoliosis in central core disease
Mertz, Kirsten D; Jost, Bernhard; Glatzel, Markus; Min, Kan
Abstract: Central core disease (CCD) is a rare congenital myopathy with autosomal dominant inheri-
tance. Here, we report on two cases of progressive scoliosis in CCD, pointing out the value of a muscle
biopsy to establish the correct diagnosis. The first case involves a 13-year-old boy with severe progressive
scoliosis and joint contractures. The patient was initially diagnosed with arthropgryposis multiplex con-
genita. The second case involves a 45-year-old man with severe scoliosis that had slowly progressed over
the years. Both patients suffered from unexplained muscle weakness and severe restriction of pulmonary
function. The correct diagnoses were established through muscle biopsies taken from the paravertebral
musculature during scoliosis surgery. Correction of the spinal deformities was achieved through posterior
instrumentation in both patients, with prior anterior release in one patient. Although scoliosis is a com-
mon feature in CCD, the correct diagnosis can be missed in scoliosis patients. Therefore, we recommend
a muscle biopsy in patients with scoliosis, unexplained muscle weakness and multiple joint problems
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Introduction
Central core disease (CCD) is a rare but benign con-
genital myopathy, ﬁrst described by Shy and Magee in
1956 [10]. Inheritance is usually autosomal dominant
[10, 17], but putative autosomal recessive inheritance has
been described [5, 11]. While the overall incidence of
CCD is rare, recent reports have documented a broader
clinical spectrum of this disorder, suggesting that the
actual incidence of CCD may be considerably higher
than previously perceived [16, 19].
Clinical presentation of CCD includes proximal
muscle weakness without or with slow progression and
hypotonia during infancy that can persist throughout
adolescence/adulthood. Symptoms can include delayed
motor development, reduced muscle bulk and skeletal
alterations such as congenital hip dislocation, ﬂat feet,
and deformities or contractures of the joints [5, 9, 13–15,
17]. However, phenotypic presentation varies consider-
ably from no visible disability to totally dependent
ambulation [16].
In this article we describe the clinical and pathologi-
cal features of two aﬀected individuals where the
diagnosis of CCD was made via a muscle biopsy taken
during scoliosis surgery. Both patients presented with
severe progressive scoliosis and unexplained muscle
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Abstract Central core disease
(CCD) is a rare congenital myopa-
thy with autosomal dominant
inheritance. Here, we report on two
cases of progressive scoliosis in
CCD, pointing out the value of a
muscle biopsy to establish the cor-
rect diagnosis. The ﬁrst case involves
a 13-year-old boy with severe pro-
gressive scoliosis and joint contrac-
tures. The patient was initially
diagnosed with arthropgryposis
multiplex congenita. The second
case involves a 45-year-old man with
severe scoliosis that had slowly pro-
gressed over the years. Both patients
suﬀered from unexplained muscle
weakness and severe restriction of
pulmonary function. The correct
diagnoses were established through
muscle biopsies taken from the par-
avertebral musculature during scoli-
osis surgery. Correction of the spinal
deformities was achieved through
posterior instrumentation in both
patients, with prior anterior release
in one patient. Although scoliosis is
a common feature in CCD, the cor-
rect diagnosis can be missed in sco-
liosis patients. Therefore, we
recommend a muscle biopsy in pa-
tients with scoliosis, unexplained
muscle weakness and multiple joint
problems.
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weakness. In the literature, only a few patients have been
reported who present scoliosis as the predominant
skeletal feature of CCD [13, 15]. The purpose of this
report is to highlight potential diﬃculties in establishing
the correct diagnosis of CCD in scoliosis patients.
Case reports
Patient 1, a 13-year-old white male, was referred to our
hospital with severe kyphoscoliosis. He had hypotonic
muscles, normal mental development, but delayed mo-
tor development. He was able to walk only a few steps
with orthopedic walking aids. Joint contractures of hips
and knees developed very early so that the initial
diagnosis of arthrogryposis multiplex congenita had
been made. Scoliosis developed at the age of 4 years.
At age ten, he had a right thoracic curve T2–T12 of 74
degrees with pulmonary vital capacity of 65% of nor-
mal. At the time of presentation, the deformity had
progressed to 80 degrees of scoliosis and 100 degrees of
kyphosis (Fig. 1). The vital capacity of the lung had
decreased to 26%. Deep tendon reﬂexes in the upper
extremities were hypoactive and missing in the lower
extremities. All extremities exhibited reduced muscle
tone with muscle weakness. Serum creatine kinase level
was within normal limits: 47 IU/l (normal<110 IU/l).
When the family history was researched, the father and
paternal grandmother of this patient were known to
have slight unexplained muscle weakness and joint
problems. The father had undergone muscle biopsy in
1985, having suﬀered from multiple musculoskeletal
problems since childhood. He was able to walk nor-
mally, but complained of muscle weakness and
increasing problems with shortened tendons and hy-
permobile joints, especially in the lower extremities.
The grandmother of this patient had presented with
various musculoskeletal problems at a young age and
was therefore diagnosed with poliomyelitis. The pedi-
gree of the family is depicted in Fig. 2.
The kyphoscoliosis of Patient 1 was treated with
posterior instrumentation and fusion from T1 to L5.
During surgery, a muscle biopsy was taken from the
erector spinae muscle at the convex side of the curve. We
reexamined the muscle biopsy of this patient’s father,
which had been judged inconclusive in 1985. The father’s
muscle biopsy evidenced the typical pattern of CCD.
The features were similar to those observed in the biopsy
of Patient 1: structural abnormalities of the muscle ﬁbers
with accumulation of basophilic material in the center of
the majority of muscle ﬁbers were observed in the
hematoxylin and eosin (HE) stain (Fig. 3).
Patient 2, a 45-year-old white male, presented with
severe scoliosis, which was evident since childhood. The
scoliosis deformity had progressed slowly over the
years. His motor skills have always been poor; he had
never been as physically active as his peers. Many
examinations had been made in several European
countries without conclusive results. Because of his tall,
thin stature, he underwent examinations to exclude
Fig. 1 Pre-operative ap and
lateral radiographs of Patient 1.
Note the severe thoraco-lumbar
kyphoscoliosis
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Marfan Syndrome. He was presented to our hospital
with the diagnosis of severe idiopathic scoliosis. At the
time of scoliosis surgery, he had a right thoracic curve
T1–T10 of 75 degrees and a left lumbar curve T11–L4
of 80 degrees (Fig. 4). He suﬀered from restricted pul-
monary function with a vital capacity of 53%. Previous
lung function tests were not available, but Patient 2
complained of progressive shortness of breath in the
last 3–4 years. Physical examination revealed that he
had slight weakness of proximal muscle groups in the
upper limbs as well as atrophy of shoulder and
Fig. 3 (a) Immunohistochemical stain for desmin of the biopsy
taken from patient 1. There is a disturbance of the normal
architecture of the muscle ﬁbers with single and central cores
(asterix). (b) Electron microscopic examination of the biopsy taken
from patient 1. Note the accumulation of electron dense material
within the central region of the muscle ﬁbers. The insert shows a
magniﬁcation of the border zone between intact (triangle) and
disturbed myoﬁbrils (arrow). (c) Nicotinic acid-dehydrogenase
(NADH) stain of the biopsy taken from patient 1. In the area of the
central cores (asterix) there is no enzymatic activity detectable,
while the rest of the muscle ﬁbers show normal enzyme activity.
(d) Periodic Acidic Schiﬀ (PAS) stain of the biopsy taken from the
Fig. 2 Pedigree of Family 1.
Three of the family members,
the paternal grandmother, the
father and the son, show typical
clinical features of central core
disease. In case of the father (2)
and the son (1) this was con-
ﬁrmed by muscle biopsy
(black). In case of the paternal
grandmother (3), who is de-
ceased, similar musculoskeletal
problems were reported by the
family members. The diagnosis
of central core disease is prob-
able but not conﬁrmed by
muscle biopsy (grey)
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parascapular musculature. Deep tendon reﬂexes were
absent in the upper limbs, but normal in the lower
limbs. Serum creatine kinase level was normal: 59 IU/l
(normal<110 IU/l). He had no family history of neu-
romuscular disease or scoliosis. A staged ventral release
from T7 to L2 and dorsal instrumentation with fusion
from T4 to L4 were performed to adjust the scoliosis
deformity. A muscle biopsy was taken from the lateral
vastus during this operation. The muscle biopsy of
Patient 2 evidenced features similar to Patient 1 and his
father (Fig. 3).
Scoliosis surgery did not cause any complications in
either patient; there were no signs of malignant
hyperthermia during general anesthesia, nor any neu-
rological complications. Intraoperative neuromonitor-
ing with sensory and motor evoked potentials revealed
no pathological activity. Scoliosis was adjusted to 50
degrees in Patient 1, and to 35 degrees thoracic and 35
degrees lumbar in Patient 2. Three years after our
initial examination, pulmonary vital capacity of Pa-
tient 1 was 30% of normal, and 41% of normal in
Patient 2.
Discussion
Although scoliosis is a common musculoskeletal feature
in patients with neuromuscular diseases, usually appar-
ent in advanced stages of the disease, the correct diag-
nosis of CCD is often missed in soliosis patients [13, 15].
Both patients in our report suﬀered from severe pro-
gressive scoliosis and showed further clinical signs of
CCD [16], namely the symmetrical muscle weakness
with varying pattern and extent, involving the trunk and
the proximal muscles of the limbs more than the distal
groups, and decreased or absent deep tendon reﬂexes,
but normal sensation. In addition, Patient 1 had multi-
ple joint contractures, another common musculoskeletal
problem in CCD [5, 17]. Patient 2 had only slight
weakness of proximal muscles of the upper limbs, mus-
cular atrophy in his shoulders, and absent deep tendon
reﬂexes in the upper limbs.
These case reports illustrate the wide spectrum of
clinical appearance of CCD, even within the same
family, ranging from apparently clinically normal to
Fig. 4 Pre-operative ap and
lateral radiographs of Patient 2
showing severe thoraco-lumbar
scoliosis
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severely disabled individuals. To our knowledge, respi-
ratory insuﬃciency has not been reported as a feature of
CCD. Therefore, the ﬁndings of both patients might be
considered unusual. In conjunction with their muscle
biopsy ﬁndings, the symptoms of the patients presented
could have led to the incorrect diagnosis of mini-core
myopathy, a condition with autosomal recessive inheri-
tance, having no linkage with malignant hyperthermia,
but association with nocturnal hypoventilation. Exami-
nation of the father of Patient 1 suggested an autosomal
dominant disorder in this family. The muscle biopsy of
Patient 1 conﬁrmed the diagnosis of CCD. An interest-
ing ﬁnding in CCD is that children are usually more
severely aﬀected than their parents [16].
The level of serum creatine phospokinase was normal
in both patients, a ﬁnding consistent with documented
reports [14]. Cases with elevated levels of serum creatine
phospokinase have also been described [9, 15] which can
be associated with episodes of malignant hyperthermia
[2, 4]. Inherited as a dominant trait, malignant hyper-
thermia is now considered to be a genetically heteroge-
neous skeletal muscle disorder characterized by a
hypermetabolic response to common inhalational anes-
thetics and depolarizing muscle relaxants [1]. Reliable
diagnosis of the malignant hyperthermia phenotype is
made using an in vitro contracture test (IVCT), where
contractile responses to caﬀeine and halothane are
measured in muscle biopsies obtained from individuals
suspected to be susceptible to malignant hyperthermia
[3, 8]. Genetic analysis has indicated that mutations in
the ryanodine receptor gene of the skeletal muscle
(RYR1), encoding the calcium release channel in the
sarcoplasmic reticulum, may be responsible for both
malignant hyperthermia and CCD [6, 20, 21]. To date,
over 35 mutations/deletions in the RYR1 gene have been
identiﬁed as co-segregating with the CCD trait [12, 18].
Out of these, twelve have been deﬁnitively shown as
resulting in susceptibility to malignant hyperthermia.
Thus, it seems likely that some mutations in RYR1 may
lead to CCD in the absence of malignant hyperthermia.
Nevertheless, CCD has been shown to be closely linked
with malignant hyperthermia and CCD patients should
not be anesthetized with any malignant hyperthermia-
triggering agents [2, 4].
Conclusions
The patients described in this report highlight the
importance of examining children and adults with pro-
gressive scoliosis of unknown etiology and a family
history of musculoskeletal problems such as muscle
weakness and joint disorders. In such cases, we recom-
mend a muscle biopsy which, in case of CCD, allows an
easy and correct diagnosis due to the typical histological
pattern. It is important for patients and treating physi-
cians to know that CCD does not necessarily indicate a
shortened life expectancy, but rather the possibility of a
slow progression of the disease [7]. Furthermore, the
autosomal dominant mode of inheritance and the in-
creased susceptibility to malignant hyperthermia should
be considered when advising individuals aﬀected by this
disease.
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